Novo Nordisk May Proceed with Its Ozempic Suit Against DCA Pharmacy. A Tennessee federal court denied DCA Pharmacy’s motion to dismiss a lawsuit ...

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

Unsoo Kim, president, CEO and MD, Wangdo Hur, executive director and CFO, and Tarun Garg, whole time director and COO of Hyundai Motor India outline their plans ...

Amneal Pharmaceuticals Inc (AMRX) reports a 17% revenue increase and raises 2024 guidance amid key product launches and strategic developments.

Nasdaq-listed Amneal Pharmaceuticals, which already operates multiple manufacturing facilities in Gujarat, is further ...

Furthermore, Amneal is expanding internationally, expecting revenues of $50 million to $100 million by 2027, and plans to launch five additional biosimilar products between 2025 and 2027.

Katherine Haan is a small business owner with nearly two decades of experience helping other business owners increase their incomes. Katherine Haan is a small business owner with nearly two ...

Amneal will also be granted a license to commercialize Metsera's products in select emerging markets, including India and certain countries in Southeast Asia, Africa and the Middle East.

"The Union Minister also met with Chirag Patel and Chintu Patel, Co-CEOs of Amneal Pharmaceuticals, to explore ways to leverage India's existing ... and that growth continues in a sustained manner in ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, and Metsera, Inc. ("Metsera"), a clinical-stage biopharmaceutical company accelerating the ...